InvestorsHub Logo
Followers 3
Posts 191
Boards Moderated 0
Alias Born 04/19/2006

Re: themurphman post# 21476

Monday, 03/03/2008 9:23:48 AM

Monday, March 03, 2008 9:23:48 AM

Post# of 346050
Peregrine has exclusively licensed bavituximab from UT Southwestern and has a sponsored research agreement to further explore clinical uses of the drug. Dr. Thorpe is a consultant to and has an equity interest in the company.

http://www.sciencedaily.com/releases/2008/03/080301214730.htm
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News